Women at high risk for breast cancer: preventive strategies
Sakorafas, G.H.
Mount Sinai Journal of Medicine new York 69(4): 264-266
2002
ISSN/ISBN: 0027-2507 PMID: 12357269 Document Number: 547179
Prevention of breast cancer is a high priority for women at risk for the disease. Management options for this group include close surveillance, chemoprevention, and prophylactic mastectomy (surgical prophylaxis). The optimal method remains to be determined. However, at the present time, close surveillance, which include breast self-examination, annual or semiannual physical examinations, and annual mammography starting at age 30, remains the most widely accepted method.
Document emailed within 1 workday
Related Documents
Kuhl, C.K. 2002: High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene) Journal of Experimental and Clinical Cancer Research: Cr 21(3 Suppl): 103-106McCredie, M.; Hopper, J.L.; Cawson, J.N. 1995: Risk factors and preventive strategies for breast cancer Medical Journal of Australia 163(8): 435-440
Moorman, P.G.; Havrilesky, L.J.; Gierisch, J.M.; Coeytaux, R.R.; Lowery, W.J.; Peragallo Urrutia, R.; Dinan, M.; McBroom, A.J.; Hasselblad, V.; Sanders, G.D.; Myers, E.R. 2013: Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(33): 4188-4198
Stefanek, M.E. 1990: Counseling women at high risk for breast cancer Oncology 4(1): 27-33; Discussion 34: 37-38
Campbell, I. 1998: Breast cancer screening policy for high risk women New Zealand Medical Journal 111(1068): 238
Dworsky, R.; Paganini-Hill, A.; Spicer, D. 1989: Breast cancer screening and education in high risk women Progress in Clinical and Biological Research 293: 115-124
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Ichida, M.; Kataoka, A.; Tsushima, R.; Taguchi, T. 2015: No increase in breast cancer risk in Japanese women taking oral contraceptives: a case-control study investigating reproductive, menstrual and familial risk factors for breast cancer Asian Pacific Journal of Cancer Prevention: Apjcp 16(9): 3685-3690
Rose, J.; Oliver, Y.; Sage, P.; Dong, W.; Koroukian, S.M.; Koopman Gonzalez, S. 2022: Factors affecting timely breast cancer treatment among black women in a high-risk urban community: a qualitative study Bmc Women's Health 22(1): 354
Spigel, D.R.; Hainsworth, J.D.; Burris, H.A.; Molthrop, D.C.; Peacock, N.; Kommor, M.; Vazquez, E.R.; Greco, F.A.; Yardley, D.A. 2011: A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer Clinical Advances in Hematology and Oncology: H&o 9(4): 280-286
Wahner-Roedler, D.L.; Petersen, I.A. 2004: Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma Drugs of Today 40(10): 865-879
Strnad, P. 1997: Hormone replacement and risk of breast carcinoma in a high-risk group of women Ceska Gynekologie 62(6): 355-361
Ivanov, I.; Baĭchev, G.; Betova, T. 2008: Breast lesions with moderate and high risk of invasive breast cancer--incidence and some particularities Akusherstvo i Ginekologiia 47(5): 17-21
Razis, E.D.; Samonis, G.; Cook, P.; Beer, M.; Mittelman, A.; Lake, D.E.; Feldman, E.J.; Puccio, C.; Ahmed, T. 1994: TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer Journal of Medicine 25(3-4): 241-250
Fenaughty, A.M.; Namyniuk, L. 2004: "Here's what I'd do...": condom promotion strategies proposed by high-risk women in Anchorage, Alaska Qualitative Health Research 14(1): 23-38
Mokbel, K. 2003: Risk-reducing strategies for breast cancer--a review of recent literature International Journal of Fertility and Women's Medicine 48(6): 274-277
Evgen'eva, I.A.; Karash, I.M.; Chizhov, A.Ia. 1989: Preventive use of intermittent normobaric hypoxic hypoxia in pregnant women at high risk of developing late toxicosis Akusherstvo i Ginekologiia 1989(6): 50-53
Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67
Hernández-Bronchud, M. 1996: Hereditary predisposition to breast cancer: assessment of genetic risk and recommendations for the clinical follow-up of high-risk cases Medicina Clinica 107(10): 383-387